Leveraging an annualized run-rate baseline of ~1M€ from late 2025, the Company accelerates its strategic rollout of ...

ABL DIAGNOSTICS (ISIN: FR001400AHX6 - Ticker: ABLD-FR), a leading company in molecular diagnostics and genotyping, announces the publication of a new research note (flash note) by Allinvest (Invest ...

Co-Diagnostics, Inc. CODX stock is trading higher on Wednesday as the company announced a private placement aimed at raising ...

ABL Diagnostics (FR001400AHX6 – “ABLD”), a specialist in molecular diagnostics, bioinformatics and infectious disease solutions, today announces its strategic commitment to integrating Artificial ...

International HIV publication further validates the DeepChek® brand for HIV genotyping and long- & short-read NGS, ...

Join us for an insightful webinar on the critical role of molecular diagnostic testing for respiratory viruses during flu season. This session will explore the importance of accurate and timely ...

According to Mordor Intelligence, the esoteric testing market size was valued at USD 27.21 billion in 2025 and is projected ...

Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx", or the "Company"), a molecular diagnostics company with a unique, patented ...

View Insight Molecular Diagnostics Inc. IMDX stock quote prices, financial information, real-time forecasts, and company news from CNN.

Molecular diagnostics hold immense potential, but their precision depends on rigorous quality control, validation, and verification processes. From assay design to data management, every step impacts ...

FDA progress for GraftAssureDx, registry momentum, launch timing, and cash burn outlook—read the key takeaways now.

Molecular diagnostic techniques are a broad range of laboratory methods that utilise the principles of molecular biology and genetics to identify and diagnose diseases, monitor treatment responses, ...